Small vessel coronary artery disease: How small can we go with myocardial revascularization?

12Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

The issue of small coronary artery atherosclerosis represents an intriguing aspect of coronary artery disease, which is related with higher rates of peri-and post-procedural complications and impaired long-term outcome. This problem is further complicated by the unclear definition of small coronary vessel. Recent randomized controlled trials have provided new data on possible novel interventional treatment of small coronary vessels with drug-coated balloons instead of traditional new-generation drug-eluting stent implantation. Also, the conservative management represents a therapeutic option in light of the results of the recent ISCHEMIA trial. The current article provides an overview of the most appropriate definition, interventional management, and prognosis of small coronary artery atherosclerosis.

Cite

CITATION STYLE

APA

Wybraniec, M. T., Bańka, P., Bochenek, T., Roleder, T., & Mizia-Stec, K. (2021). Small vessel coronary artery disease: How small can we go with myocardial revascularization? Cardiology Journal. Via Medica. https://doi.org/10.5603/CJ.a2020.0127

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free